This isn’t just about legal technicalities; it’s about New Yorkers’ livelihoods and ability to make ends meet.
Janssen Pharmaceuticals v. A.Y.
(U.S., filed March 8, 2021): Urging the Court to address whether FDA regulations permit a manufacturer unilaterally to implement an off-label warning via a CBE or does the addition of an off-label warning require FDA approval.
Plaintiff-friendly courts tilt the scales of justice at will.
Report Reveals Ongoing Crisis and Urgent Need for Reform
Evolution in Legal Landscape and Emerging Challenges Highlighted
St. Louis’ Legal Woes Exposed as Trial Lawyer Contributions Stall Reform
From Coasts to Courts, State Struggles Under Weight of Judicial Hellholes® Title